Cargando…
Challenging issues in the management of cancer-associated venous thromboembolism
Venous thromboembolism (VTE) is a common complication among patients with cancer and is associated with delays in underlying cancer treatment and increases in morbidity and mortality. Acute and long-term treatments with low-molecular-weight-heparin (LMWH) have been recommended as a standard of care...
Autor principal: | Yhim, Ho-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057672/ https://www.ncbi.nlm.nih.gov/pubmed/35483925 http://dx.doi.org/10.5045/br.2022.2022025 |
Ejemplares similares
-
Current Management of Cancer-associated Venous Thromboembolism: Focus on Direct Oral Anticoagulants
por: Kim, Sang-A, et al.
Publicado: (2019) -
Direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism
por: Yhim, Ho-Young, et al.
Publicado: (2014) -
Incidence of venous thromboembolism in Korea from 2009 to 2013
por: Hong, Junshik, et al.
Publicado: (2018) -
Incidence of Venous Thromboembolism: The 3(rd) Korean Nationwide Study
por: Hwang, Hun-Gyu, et al.
Publicado: (2022) -
Updated recommendations for the treatment of venous thromboembolism
por: Hong, Junshik, et al.
Publicado: (2021)